Cargando…
Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13
BACKGROUND: Estrogen Receptor alpha (ERα)-positive breast cancer patients receive endocrine therapy, often in the form of tamoxifen. However, resistance to tamoxifen is frequently observed. A signalling cascade that leads to tamoxifen resistance is dictated by activation of the Protein Kinase A (PKA...
Autores principales: | Bentin Toaldo, Cristiane, Alexi, Xanthippi, Beelen, Karin, Kok, Marleen, Hauptmann, Michael, Jansen, Maurice, Berns, Els, Neefjes, Jacques, Linn, Sabine, Michalides, Rob, Zwart, Wilbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536754/ https://www.ncbi.nlm.nih.gov/pubmed/26272591 http://dx.doi.org/10.1186/s12885-015-1591-4 |
Ejemplares similares
-
Visualizing the action of steroid hormone receptors in living cells
por: Griekspoor, Alexander, et al.
Publicado: (2007) -
A Role for Estrogen Receptor Phosphorylation in the Resistance to Tamoxifen
por: de Leeuw, Renée, et al.
Publicado: (2011) -
IGF‐1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER‐positive breast cancer
por: Kruger, Dinja T., et al.
Publicado: (2019) -
Flagellar Radial Spoke Protein 3 Is an a-Kinase Anchoring Protein (Akap)
por: Gaillard, Anne Roush, et al.
Publicado: (2001) -
G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential signaling to MAPK and GPCR recycling
por: Tao, Jiangchuan, et al.
Publicado: (2008)